MiNK Therapeutics to Participate in 4th Annual Evercore ISI HealthCONx Conference
NEW YORK, Nov. 17, 2021 (GLOBE NEWSWIRE) -- MiNK Therapeutics, a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic,…